These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2554665)

  • 1. [P-8502--a new mu selective opioid receptor ligand].
    Ge BL; Zhang HP; Xu YP; Zheng WJ
    Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):13-6. PubMed ID: 2554665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of the long-acting analgesics 3-(beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicycles [3,3,1]-nonane (P-7521) on opiate receptor binding in vitro].
    Zhou DH; Ge BL; Xu XJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 Nov; 9(6):511-5. PubMed ID: 2855686
    [No Abstract]   [Full Text] [Related]  

  • 3. P-7521--a new irreversible opioid ligand.
    Jin WQ; Fan LQ; Chen XJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):205-10. PubMed ID: 2558497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of 9 slowly dissociated opioid ligands azabicyclononances compounds to mu, delta, and kappa receptors].
    Fan LQ; Jin WQ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1991 May; 12(3):245-9. PubMed ID: 1664168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of potent analgesic 3-(beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicyclo [3,3,1]-nonane (p-5721) on electroencephalography in rabbits].
    Zhao GM; Zhou J; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):300-3. PubMed ID: 3195338
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analgesic activity and respiratory inhibition of 3-beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicyclo [3,3,1]-nonane (P-7521) in rabbits].
    Zhou J; Zheng WJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1987 Jan; 8(1):10-3. PubMed ID: 2955652
    [No Abstract]   [Full Text] [Related]  

  • 7. A potent and long-lasting ligand, azabicyclononane (P-7521).
    Chi ZQ; Jin WQ
    Prog Clin Biol Res; 1990; 328():1-4. PubMed ID: 2154758
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanes.
    Barlocco D; Fadda P; Fratta W
    Farmaco; 1993 Mar; 48(3):387-96. PubMed ID: 8391821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicifadine: non-narcotic analgesic activity of 1-aryl-3-azabicyclo[3.1.0] hexanes.
    Epstein JW; Osterberg AC; Regan BA
    NIDA Res Monogr; 1982 Apr; 41():93-8. PubMed ID: 6811945
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptors.
    Cignarella G; Barlocco D; Tranquillini ME; Volterra A; Brunello N; Racagni G
    Pharmacol Res Commun; 1988 May; 20(5):383-94. PubMed ID: 2843931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between analgesic activity and opiate receptor binding affinity of 5 derivatives of 3-aza-bicyclo(3,3,1)nonanes].
    Wang DY; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):158-63. PubMed ID: 6095589
    [No Abstract]   [Full Text] [Related]  

  • 12. [CNS-active 4-phenylpyranes: 9-phenyl-9-piperidino-3-oxa-7-azabicyclo[3.3.1]nonane].
    Eiden F; Schmidt M; Deus-Neumann B; Zenk MH
    Arch Pharm (Weinheim); 1987 Feb; 320(2):130-4. PubMed ID: 3034190
    [No Abstract]   [Full Text] [Related]  

  • 13. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
    Adams JU; Tallarida RJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and analgesic activity of some 5-(4-hydroxyphenyl)-2-azabicyclo[3.2.1]octanes.
    Ong HH; Anderson VB; Wilker JC; Spaulding TC; Meyerson LR
    J Med Chem; 1980 Jul; 23(7):726-9. PubMed ID: 6249930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on structure-activity relationships and receptor binding feature for 3-methylfentanyl derivatives].
    Weng JH; Xu XR; Zhu YC; Zhou J; Xu H; Chi ZQ
    Yao Xue Xue Bao; 1990; 25(3):178-85. PubMed ID: 2173349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):330-6. PubMed ID: 1656027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.